Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells.

Cromer MK, Vaidyanathan S, Ryan DE, Curry B, Lucas AB, Camarena J, Kaushik M, Hay SR, Martin RM, Steinfeld I, Bak RO, Dever DP, Hendel A, Bruhn L, Porteus MH.

Mol Ther. 2018 Jul 10. pii: S1525-0016(18)30261-2. doi: 10.1016/j.ymthe.2018.06.002. [Epub ahead of print]

PMID:
30005866
2.

CRISPR/Cas9 genome editing in human hematopoietic stem cells.

Bak RO, Dever DP, Porteus MH.

Nat Protoc. 2018 Feb;13(2):358-376. doi: 10.1038/nprot.2017.143. Epub 2018 Jan 25.

3.

Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6.

Bak RO, Dever DP, Reinisch A, Cruz Hernandez D, Majeti R, Porteus MH.

Elife. 2017 Sep 28;6. pii: e27873. doi: 10.7554/eLife.27873.

4.

The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.

Dever DP, Porteus MH.

Curr Opin Hematol. 2017 Nov;24(6):481-488. doi: 10.1097/MOH.0000000000000385. Review.

PMID:
28806273
5.

Technical considerations for the use of CRISPR/Cas9 in hematology research.

Gundry MC, Dever DP, Yudovich D, Bauer DE, Haas S, Wilkinson AC, Singbrant S.

Exp Hematol. 2017 Oct;54:4-11. doi: 10.1016/j.exphem.2017.07.006. Epub 2017 Jul 27. Review.

PMID:
28757433
6.

CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.

Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, Pavel-Dinu M, Saxena N, Wilkens AB, Mantri S, Uchida N, Hendel A, Narla A, Majeti R, Weinberg KI, Porteus MH.

Nature. 2016 Nov 17;539(7629):384-389. doi: 10.1038/nature20134. Epub 2016 Nov 7.

7.

Aryl hydrocarbon receptor deletion in cerebellar granule neuron precursors impairs neurogenesis.

Dever DP, Adham ZO, Thompson B, Genestine M, Cherry J, Olschowka JA, DiCicco-Bloom E, Opanashuk LA.

Dev Neurobiol. 2016 May;76(5):533-50. doi: 10.1002/dneu.22330. Epub 2015 Aug 17.

8.

The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells.

Dever DP, Opanashuk LA.

Mol Pharmacol. 2012 May;81(5):669-78. doi: 10.1124/mol.111.077305. Epub 2012 Feb 6.

9.

Subchronic polychlorinated biphenyl (Aroclor 1254) exposure produces oxidative damage and neuronal death of ventral midbrain dopaminergic systems.

Lee DW, Notter SA, Thiruchelvam M, Dever DP, Fitzpatrick R, Kostyniak PJ, Cory-Slechta DA, Opanashuk LA.

Toxicol Sci. 2012 Feb;125(2):496-508. doi: 10.1093/toxsci/kfr313. Epub 2011 Nov 17.

10.

2,3,7,8-Tetracholorodibenzo-p-dioxin exposure disrupts granule neuron precursor maturation in the developing mouse cerebellum.

Collins LL, Williamson MA, Thompson BD, Dever DP, Gasiewicz TA, Opanashuk LA.

Toxicol Sci. 2008 May;103(1):125-36. doi: 10.1093/toxsci/kfn017. Epub 2008 Jan 27.

PMID:
18227101
11.

Primary malignant melanoma of the scrotum: case report and literature review.

Davis NS, Kim CA, Dever DP.

J Urol. 1991 May;145(5):1056-7. Review.

PMID:
2016794
12.

Case profile: prostatic adenoma masquerading as primary urethral neoplasm.

Donahue LA, Dever DP.

Urology. 1988 Oct;32(4):364-5. No abstract available.

PMID:
2459832
13.

Nutcracker phenomenon.

Dever DP, Ginsburg ME, Millet DJ, Feinstein MJ, Cockett AT.

Urology. 1986 Jun;27(6):540-2. No abstract available.

PMID:
3716053
14.

Appendiceal abscess masquerading as acute urinary retention in children.

Dever DP, Hulbert WC Jr, Emmens RW, Rabinowitz R.

Urology. 1985 Mar;25(3):289-92.

PMID:
3883631
15.

Renal infarct.

Dever DP, Davis RS.

N Y State J Med. 1984 May;84(5):258-60. No abstract available.

PMID:
6588324
16.

Penile fracture: operative management and cavernosography.

Dever DP, Saraf PG, Catanese RP, Feinstein MJ, Davis RS.

Urology. 1983 Oct;22(4):394-6.

PMID:
6636395
17.

Urinary incontinence.

Dever DP, Hulbert WC Jr, Stubbings MJ, Valvo JR, Cockett AT.

Am Fam Physician. 1983 Aug;28(2):123-32.

PMID:
6881005

Supplemental Content

Loading ...
Support Center